Mammography Market

Global Mammography Market Size (2024 to 2029)

The global mammography market is estimated to be worth USD 2580 million by 2028 and USD 1919 million in 2023, growing at a CAGR of 6.10% during the forecast period.

Breast cancer remains the most common cause of death among women worldwide. The high mortality rate has increased the need to diagnose breast cancer patients and resulted in a rising demand for mammography devices. These devices help in the early detection and diagnosis of breast disease among women. Mammography is a standard screening and diagnostic technique used to screen breast tissues for malignant tissues. It involves detailed imaging inside the breast with a low-dose X-ray system for the early detection of cancer. Screening mammograms involve checking for breast cancer among women with no signs of the disease. A Diagnostics mammogram monitors breast cancer after a lump or other symptom of the disease. It can also be used to evaluate the changes found during screening mammography.

MARKET DRIVERS

The growing patient count of breast cancer is the primary driving factor for the mammography market.

Along with this, advancements in breast imaging technologies, rapid growth in the aging population, and increasing awareness resulting in early breast cancer screening propel the market's growth. Nearly 2.3 million women are diagnosed with breast cancer globally. Technological advancements in the mammography systems market will offer many profitable opportunities. The government conducts an educational awareness program for patients at a high risk of breast cancer. They should also explain the symptoms of severe breast cancer; breast self-examination and clinical examination should be necessary. Increasing research and development in mammography for people's convenience drives the market forward during the forecast period.

Increasing demographics and income in countries such as India and China are anticipated to offer better global mammography market opportunities. A mammography coach provides opportunities for clinicians. In addition, the rise in knowledge regarding the importance of screening is to enhance the growth rate of this market.

MARKET RESTRAINTS

However, this treatment procedure's side effects and the imaging system's high cost will likely restrain the global mammography market demand.

Furthermore, lack of awareness over the availability of treatment procedures, especially in rural areas, limits the market's demand. Furthermore, the lack of skilled professionals in mammography examination and the lack of instruments in some areas impede market growth. In addition, the government's complex regulatory system is hindering the mammography market's growth rate.

Impact of COVID-19 on the global mammography market

COVID-19 was declared a pandemic by the World Health Organization (WHO) in March 2020. As a result, Lockdown restrictions hit the world in the initial months of 2020, where all the treatment procedures except treatment for COVID-19 patients were postponed or canceled. During this time, the mammography market demand has declined as fewer patients visit the hospitals unless it's an emergency. However, from the last months of 2020, all the activities were resumed with the government's unlock guidelines. However, the mammography market is anticipated to showcase a healthy CAGR during the forecast period.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Mammography Market By Product

Based on the product, the digital systems segment led the mammography market in 2023.

The 3D mammography systems segment is also the fastest-growing segment due to the Medical Imaging Modernization Act's presence. 3D mammography system can create 2D and 3D pictures of the breasts. This tool also improves the ability of mammography to detect early breast cancers and decreases the additional test if the person is detected with cancer or not.

The biopsy systems segment accounts for a substantial market share during the forecast period. Increasing breast biopsy procedures to remove a sample of breast tissue for testing will drive the mammography market forward. This procedure is recommended for people with signs of cancer and brush lumps. Additionally, this is the final test to detect whether it is cancer. As a result, this procedure is the main one in the mammography process to treat people correctly.

Mammography Market By Technology

Based on technology, the digital systems segment holds the highest share of the market during the forecast period. One of the major factors anticipated to drive the market is the rise in demand for advanced technological breast cancer screening and diagnosis. In this digital mammography, multiple images of the breast are recorded at different angles to know the correct location of cancer development. This is used for early screening and diagnosis of breast cancer. Digital mammography uses computer-based electronic conductors to display a picture clearly and the most accurate images, which helps for correct diagnosis. In addition, the advancements in digital mammography use deep learning artificial intelligence (A.I.) techniques to detect and classify lesions suspicious of breast cancer automatically.

The breast tomosynthesis segment is yet to show a moderate CAGR value in the coming years. This has become the most significant technological development in the global mammography market in recent years. Growing demand for advanced technology and a rise in awareness over the availability of advanced cancer detection techniques are the vital attributes accelerating the need for the market.

Mammography Market By Application

New technologies are continually being developed and modified based on the Application, resulting in better imaging capabilities as the technology becomes more widespread. The global shift is more inclined towards digital technologies, away from analog technologies.

The screening application segment has the highest market share. Screening is used to examine whether the cancer is present in the body. Breast screening is used most widely due to the increase in early breast cancer detection cases. This screening is used in mammography, which is used to detect breast cancer and pre-breast cancer. Every woman over 50 should have mammography regularly, driving the market forward. The United States Preventive Services Task Force organizations help the people by increasing research to prevent diseases and increasing awareness programs on how doctors can help in the early detection of diseases. Therefore, the mammography screening segment has the highest market share.

REGIONAL ANALYSIS

Regionally, the mammography market in North America currently dominates the global market owing to the increasing cancer population and higher affordability. As a result, this region will likely continue its dominance over the forecast period. U.S. mammography is estimated to perform at the highest CAGR in North America, followed by Canada. The United States Preventive Services Task Force organizations help the people by increasing research to prevent diseases and increasing awareness programs on how doctors can help in the early detection of diseases. This organization in the United States states that women aged between 50-65 may risk getting breast cancer every two years.

The mammography market in the European market is driven by the rising incidence of breast cancer, well-organized healthcare infrastructure, and increasing government initiatives. Mammography is the only screening test recommended by the European Commission for women aged 50–69. European use digital mammography for screening breasts to get a better result. In the U.K., more than 2 million women have breast cancer screening every year. The NHS Breast Screening Programme invites all women aged 50 to 70 for screening every three years because most women are not concentrating on this mammography program. Most women in the U.K. do not have their first screening mammogram until they are 52 years. Awareness programs are increased to take this mammography for the early detection of cancer to prevent death in this region, driving the market forward. As a result, the U.K. mammography market is anticipated to have the highest market share in the European market during the forecast period.

Meanwhile, the mammography market in Asia Pacific is the fastest growing and registering a tremendous CAGR during the forecast period. Growing economies such as India and China are expected to produce profitable outcomes due to vital changes in the people living in urban areas. Several people diagnosed with breast cancer in China are increasing every year by introducing advancements in breast cancer screening and increasing the survival rate. Treatment ensured a high and improved survival rate. Several national breast cancer screening programs have been conducted by the Chinese government, such as the Chinese One Million Women Breast Cancer Screening and Breast Cancer Screening Program, which drives the market forward. It leads to a standard increase in breast cancer. Therefore, Australia is deemed to have a significant growth rate in the coming years.

The mammography market in Latin America is expected to grow steadily during the forecast period. Among different countries of Latin America, the Brazilian market is expected to be top in this region due to the growing incidence of breast cancer and technological developments. Most of the women in Brazil are prone to death due to breast cancer. Breast cancer death is in the fifth position in Brazil. There are nearly 70,000 cases of breast cancer reported every year. So, increasing mammography for these breast examinations will drive the market ahead in this region during the forecast period.

The mammography market in MEA is anticipated to register a moderate CAGR in the global market throughout the forecast period due to low discretionary income and poor reimbursement policies. Now mammography is currently available in all regions of Middle East Africa. However, the number of programs has been increasing in Saudi Arabia, which creates an opportunity for market growth in the coming years. This Cancer screening programs help in the reduction of cancer mortality and are less costly and less harmful. In Saudi Arabia, the Ministry of Health of Saudi Arabia recommends having breast screening every year for patients with changes and pain in their breasts.

The UAE mammography market is likely to lead the market with the highest CAGR during the review period. Increasing breast cancer cases are driving market growth. Israel holds the largest market share over the UAE due to advanced technologies. In addition, it is increasing the stipulation for mammography.

KEY MARKET PARTICIPANTS

The global mammography market profiled in this report is FujifG.£.m, G.E. Healthcare, Hologic, Metaltronica, Philips Healthcare, Planmed, Siemens Healthcare, Sonocine, and Toshiba Medical Systems.

RECENT MARKET HAPPENINGS

• At the SBI/ACR Breast Imaging Symposium 2022 in Savannah, Georgia, Volpara Health announced that it had updated its devices to deliver personalized breast care. The mammography quality and reporting, volumetric breast density measures, and cancer risk assessment are all given by Volpara's AI-driven breast software tools. The instruments help clinicians to deliver a better, personalized, and optimized cancer screening experience.
• In 2022, ScreenPoint Medical announced it had gotten FDA clearance for the Transpara® AI breast care system. Based on its functionality that actively supports detection and diagnosis, it used artificial intelligence (A.I.) applications for identifying breast cancer in screening mammography.
• In 2020, Hologic, Inc. announced that it had got U.S. FDA clearance and increased the availability of the Company's Genius AI™ Detection technology. It uses deep learning-based software to help radiologists detect cancers in breast tomosynthesis images.
• In 2020, Candelis, Inc partnered with G.E. Healthcare for the business enhancement of mammography workflow, image management, and storage capabilities for the Senographe Pristina Mammography System.
• In January 2020, the first breast biopsy was performed under the guidance of angiomammography using the Pristina Serena biopsy robot by the European mammography divisioG.E.of G.E. Healthcare in France.
• In June 2019, a nationwide campaign was announced by the FujiFilm Medical Systems of USA to learn about mammography screening services and breast health. This campaign is entitled "Aspire to Be Fearless" for every woman who needs it and mainly for the woman who is unwilling to know about it.

DETAILED SEGMENTATION OF THE GLOBAL MAMMOGRAPHY MARKET INCLUDED IN THIS REPORT

This research report on the global mammography market has been segmented and sub-segmented based on the product, technology, application, and region.

By Product

• 3D Mammograms
• Digital
• Analog System
• Film Screens
• Biopsy Systems.
• Others

By Technology

• Analog
• Digital
• Breast Tomosynthesis

By Application

• Screening
• Diagnostics

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa